![Morgan Conn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Morgan Conn
Keine laufenden Positionen mehr
Vermögen: 163 278 $ am 31.08.2026
Profil
Morgan Conn formerly worked at PTC Therapeutics, Inc., as Vice President-Business Development from 2001 to 2017, Amherst College, as Assistant Professor, Century Therapeutics, Inc., as Chief Financial Officer from 2024 to 2025, and Pharvaris NV, as Chief Business Officer from 2017 to 2024.
Dr. Conn received his doctorate degree from Massachusetts Institute of Technology and undergraduate degree from the University of Toronto.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.03.2025 | 79’648 ( 0.04% ) | 163 278 $ | 31.08.2026 |
Ehemalige bekannte Positionen von Morgan Conn
| Unternehmen | Position | Ende |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Finanzdirektor/CFO | 11.07.2025 |
| PHARVARIS N.V. | Corporate Officer/Principal | 04.10.2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2017 |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Morgan Conn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
